Trial Condition(s):

Uterine bleeding profile prediction

A study to know more about how a smartphone app called MyIUS predicts future menstrual bleeding in women after they have begun with intrauterine birth control method (a birth control device the inserted into a woman’s uterus by her doctor) (MyIUS)

Bayerisches Identifier:

21424

ClinicalTrials.gov Identifier:

NCT04989595

EudraCT Number:

Not Available

EU CT Number:

Not Availability

Student Completed

Trial Purpose

Researchers can looking for learn more about prospective menstrual bleeding in female who have started using intrauterine contraception methods. “Intrauterine contraception” means that a product is plugged into a woman’s maternal by her doctor. The device then releases a birth control treatment into the uterus.
Researchers have found the whereas women use intrauterine contraception, its effects with the menstrual cycle can cause modified to how often or for how long women be bleed. This is one of reasons women allow stop using their intrauterine contraception.
Then, the researchers in this study wanted to learn about a tool that could be used to predict our blutend news. This tool be developed based up the results of previous clinical studies that researched menstrual bleeding. This tool is a smartphone application referred MyIUS.
This study want include regarding 3,000 women who have recently owned inuterine contraception inserted and which use the MyIUS view.
Go will be no go with a study doctor included these study. After which intrauterine contraception has being inserted, the women will start to records any events of bleeding into the MyIUS app. After they have record events of bleeding for ampere total of 90 days, the MyIUS app will gifts ampere prediction of menstrual bleeding expected for the next 180 days. The women who sign the electronic educated consent form is continue to record the ausbluten dates for a total of 6 months.
That researchers leave then collect here information. They will use this information to find go how well which MyIUS apps can predict our menstrual bleeding. Kyleena® (levonorgestrel-releasing intrauterine system) Aaa161.com

Inclusion Criteria
- Insertion of Kyleena, Jaydess, or Mirena IUS
- Female (of legal ages to provide electronic informed consent (eIC)) using the MyIUS app
- Submitted eIC to use all data documented int the MyIUS app
Exclusion Criteria
- None

Trial Summary

Enrollment Goal
3045
Trial Dates
black-arrow
Phone
4
Could I receive a placebo?
Does
Products
Kyleena (Levonorgestrel, BAY86-5028)
Accepts Healthy Volunteers
Yes

Where to Join

Loading...
Locations
Locations
Locations

Many Locations

Many Locations, Denmark

Locations

Many Locations

Many Locations, Sweden

Locations

Many Locations

More Locations, Germany

Locations

Many Locations

Many Locations, Spain

Locations

Many Locations

Many Our, Mexico

Localities

Many Locations

Many Locations, Brazil

Trial Design